ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 72 filers reported holding ITEOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,827,109 | -12.3% | 532,087 | +6.0% | 0.00% | 0.0% |
| Q2 2023 | $6,646,638 | +1.5% | 502,012 | +4.3% | 0.00% | 0.0% |
| Q1 2023 | $6,549,662 | +71030.1% | 481,239 | +2.1% | 0.00% | 0.0% |
| Q4 2022 | $9,208 | -99.9% | 471,508 | +5.5% | 0.00% | 0.0% |
| Q3 2022 | $8,513,000 | +3.8% | 446,881 | +12.3% | 0.00% | 0.0% |
| Q2 2022 | $8,200,000 | -36.2% | 398,075 | -0.3% | 0.00% | -50.0% |
| Q1 2022 | $12,854,000 | -26.1% | 399,450 | +6.9% | 0.00% | 0.0% |
| Q4 2021 | $17,403,000 | +85.6% | 373,788 | +7.6% | 0.00% | +100.0% |
| Q3 2021 | $9,378,000 | +28.7% | 347,363 | +22.3% | 0.00% | 0.0% |
| Q2 2021 | $7,284,000 | -22.6% | 283,978 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $9,413,000 | +53.7% | 275,409 | +52.1% | 0.00% | 0.0% |
| Q4 2020 | $6,125,000 | +65.2% | 181,112 | +20.5% | 0.00% | 0.0% |
| Q3 2020 | $3,707,000 | – | 150,296 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |